EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers

Multisite chronischer Schmerz: Zusammenhang mit kognitivem Abbau und postmortalen Alzheimer-Biomarkern

Tyler R Bell iD, Carol E Franz, Imanuel R Lerman, McKenna E Williams, Christine Fennema-Notestine iD, Matthew S Panizzon, Jeremy A Elman iD, David A Bennett iD, William S Kremen iD

Brain Communications · 2025-04-30 · 7 (3)

DOI: 10.1093/braincomms/fcaf208 ↗

Auf einen Blick

Bei älteren Erwachsenen war multisite chronischer Schmerz mit stärkerem kognitivem Abbau und mehr Aβ-Ablagerung verbunden. Einzelstellen-Schmerz unterschied sich von schmerzfrei nicht.

Fragestellung

Zusammenhang von multisite und single-site chronischem Schmerz mit kognitivem Abbau und postmortalen Alzheimer-Biomarkern bei älteren Erwachsenen ohne Demenz.

Methode

Längliche prospektive Beobachtungsstudie mit Daten aus der Religious Orders Study und dem Rush Memory and Aging Project; kognitive Tests wiederholt, Biomarker post mortem.

Ergebnisse

3.459 Teilnehmende ohne Demenz zu Studienbeginn; multisite chronischer Schmerz n=354, single-site n=506, kein chronischer Schmerz n=2.599. Multisite Schmerz war mit steilerem Abbau von globaler Kognition, episodischem Gedächtnis und Arbeitsgedächtnis verbunden sowie mit mehr Aβ in Entorhinalcortex und Hippocampus.

Schlussfolgerung der Autor:innen

Multisite, aber nicht single-site, chronischer Schmerz war mit steilerem kognitivem Abbau und erhöhter Aβ-Ablagerung verbunden, besonders bei erhöhtem genetischem Alzheimer-Risiko.

Kernaussagen

  • Multisite Schmerz: stärkere Abnahme von globaler Kognition, episodischem und Arbeitsgedächtnis
  • Mehr Aβ-Ablagerung in Entorhinalcortex und Hippocampus
  • Single-site Schmerz unterschied sich nicht von schmerzfrei

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Brain Communications, published online on 2025-05-28. Written by Tyler R Bell and 8 co-authors. Institution: Department of Psychiatry and Center for Behavior Genetics of Aging, University of California San Diego, San Diego, CA 92093, USA. Cited 13 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIA NIH HHS, NIMH NIH HHS, Religious Orders Study/Memory Aging Project.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Multisite chronic pain is a risk factor for Alzheimer’s disease, but its relationship with Alzheimer’s pathology remains unclear. This study examines the association between multisite chronic pain and single-site chronic pain with cognitive decline and post-mortem Alzheimer’s biomarkers in older adults. We conducted a longitudinal and prospective observational study using data from 3459 participants without dementia at baseline in the Religious Orders Study and Rush Memory and Aging Project. Participants (mean age = 77.94, SD = 7.93 years) were followed for an average of 8.53 years (SD = 5.74), with cognitive assessments and post-mortem biomarker analyses in a subset of brain donors (n range from 863 to 987 based on assay quality and tissue preservation). Cognitive function was measured using repeated assessments of five cognitive domains and a global composite score. Chronic pain was classified based on self-reported pain, determined by the number of joint sites affected during the first two assessments: Multisite chronic pain was defined as chronic pain in more than one site, single-site chronic pain as chronic pain in one site, and no chronic pain as no chronic pain sites. Brain beta-amyloid (Aβ) load and tau tangle density were assessed post-mortem, ∼10 months after the last clinical evaluation. This was assessed as a global measure across eight Alzheimer’s-affected brain regions, as well as specifically in the entorhinal cortex and hippocampus. Apolipoprotein-ɛ4 genotype was determined from blood and tissue samples. Compared to individuals with single-site (n = 506) or no chronic pain (n = 2599), participants with multisite chronic pain (n = 354) showed steeper declines in global cognition, episodic memory and working memory—especially among those with higher apolipoprotein-ɛ4 load—and were more likely to develop Alzheimer’s dementia. Multisite chronic pain was also linked to increased Aβ deposition in the entorhinal cortex and hippocampus, particularly in apolipoprotein-ɛ4 carriers. Compared to people with no chronic pain, single-site chronic pain did not differ on rate of cognitive decline, Alzheimer’s dementia risk or post-mortem Alzheimer’s biomarkers. Multisite, but not single-site, chronic pain is linked to steeper cognitive decline and increased Aβ deposition, particularly in individuals with elevated Alzheimer’s genetic risk. These findings suggest that reducing pain may mitigate the risk of cognitive decline and dementia.

Subjects

Author keywords

APOE ɛ4Alzheimer’s riskchronic paincognitive declineolder adults

Authors and institutions

  • Department of Psychiatry and Center for Behavior Genetics of Aging, University of California San Diego, San Diego, CA 92093, USA.
  • Department of Anesthesiology, University of California San Diego, San Diego, CA 92093, USA.
  • Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.

ORCID profiles: Tyler R Bell, Christine Fennema-Notestine, Jeremy A Elman, David A Bennett, William S Kremen

Funding

  • NIA NIH HHS
  • NIMH NIH HHS
  • Religious Orders Study/Memory Aging Project
  • National Institute on Aging
  • National Institutes of Health

Cite

APA

Bell, T. R., Franz, C. E., Lerman, I. R., Williams, M. E., Fennema-Notestine, C., Panizzon, M. S., Elman, J. A., Bennett, D. A., & Kremen, W. S. (2025). Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers. Brain Communications, 7(3). https://doi.org/10.1093/braincomms/fcaf208

Vancouver

Bell TR, Franz CE, Lerman IR, Williams ME, Fennema-Notestine C, Panizzon MS, et al. Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers. Brain Communications. 2025;7(3). doi:10.1093/braincomms/fcaf208

BibTeX
@article{Bell2025,
  author = {Bell, Tyler R and Franz, Carol E and Lerman, Imanuel R and Williams, McKenna E and Fennema-Notestine, Christine and Panizzon, Matthew S and Elman, Jeremy A and Bennett, David A and Kremen, William S},
  title = {Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers},
  journal = {Brain Communications},
  year = {2025},
  volume = {7},
  number = {3},
  doi = {10.1093/braincomms/fcaf208}
}
Start for free →